Suja Life raises $187M in Nasdaq IPO priced at low end of range
What's the deal? Suja Life, a cold-pressed juice and functional beverage maker based in Oceanside, California, has gone public on the Nasdaq under the ticker SUJA. The company raised $187M by offering 8.9 million shares at $21 — the low end of its $21 to $24 target range.
Goldman Sachs, Jefferies, William Blair, BofA Securities, and Evercore ISI acted as joint bookrunners. Roughly 2% of the shares offered were secondary.
Why now? Suja operates at the intersection of two hot consumer trends: functional beverages and better-for-you brands. Its portfolio — spanning the Suja Organic, Vive Organic, and Slice labels — covers cold-pressed juices, wellness shots, and functional sodas aimed at health-conscious consumers. The company also owns a vertically integrated manufacturing facility in North America, giving it tighter control over production costs.
The IPO window for consumer brands has been selective but open, and Suja likely moved to capitalise on sustained investor appetite for health-and-wellness plays.
What could go wrong? Pricing at the bottom of the range signals lukewarm demand. Investors may be cautious about the competitive landscape — Suja faces pressure from both legacy beverage giants expanding into functional drinks and a growing cohort of challenger brands.
Cold-pressed juice also carries higher production and logistics costs than shelf-stable beverages, which could squeeze margins as the company scales.
The signal: Suja's listing reflects broader momentum in the functional beverage category, where consumers are increasingly swapping sodas and sugary juices for products marketed around immunity, gut health, and natural ingredients. The fact that it reached the public markets at all — with a vertically integrated supply chain and a multi-brand portfolio — suggests investors see room for a scaled pure-play in the space, even if they're not willing to pay a premium for it just yet.
Read more: renaissancecapital.com
